ID   TAOK3_RAT               Reviewed;         898 AA.
AC   Q53UA7;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   24-JUL-2024, entry version 122.
DE   RecName: Full=Serine/threonine-protein kinase TAO3;
DE            EC=2.7.11.1;
DE   AltName: Full=Axotomy-related gene 357 protein;
DE   AltName: Full=JNK/SAPK-inhibitory kinase;
DE   AltName: Full=Jun kinase-inhibitory kinase;
DE   AltName: Full=Thousand and one amino acid protein 3;
GN   Name=Taok3; Synonyms=Arg357, Jik;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=16092929; DOI=10.1111/j.1471-4159.2005.03389.x;
RA   Wakabayashi T., Kosaka J., Oshika T.;
RT   "JNK inhibitory kinase is up-regulated in retinal ganglion cells after
RT   axotomy and enhances BimEL expression level in neuronal cells.";
RL   J. Neurochem. 95:526-536(2005).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-331; SER-343;
RP   SER-349 AND SER-442, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine-protein kinase that acts as a regulator of
CC       the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK
CC       cascade. Acts as an activator of the p38/MAPK14 stress-activated MAPK
CC       cascade. In response to DNA damage, involved in the G2/M transition DNA
CC       damage checkpoint by activating the p38/MAPK14 stress-activated MAPK
CC       cascade, probably by mediating phosphorylation of upstream MAP2K3 and
CC       MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and
CC       diminishes its activation in response epidermal growth factor (EGF) (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Self-associates. Interacts with ERN1 and TRAF2. Interaction
CC       with TRAF2 is facilitated under ER stress conditions, such as treatment
CC       with tunicamycin, and may promote TRAF2 phosphorylation (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with a higher expression in
CC       the retina. {ECO:0000269|PubMed:16092929}.
CC   -!- PTM: Autophosphorylated. Phosphorylation at Ser-324 by ATM following
CC       DNA damage is required for activation of the p38/MAPK14 stress-
CC       activated MAPK cascade. Phosphorylated by LRRK2 (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB195232; BAD97370.1; -; mRNA.
DR   RefSeq; NP_001019425.1; NM_001024254.1.
DR   AlphaFoldDB; Q53UA7; -.
DR   SMR; Q53UA7; -.
DR   IntAct; Q53UA7; 1.
DR   STRING; 10116.ENSRNOP00000074994; -.
DR   iPTMnet; Q53UA7; -.
DR   PhosphoSitePlus; Q53UA7; -.
DR   PaxDb; 10116-ENSRNOP00000001503; -.
DR   Ensembl; ENSRNOT00055002867; ENSRNOP00055002151; ENSRNOG00055001772.
DR   Ensembl; ENSRNOT00060011316; ENSRNOP00060008446; ENSRNOG00060006900.
DR   Ensembl; ENSRNOT00065008726; ENSRNOP00065006183; ENSRNOG00065005822.
DR   GeneID; 304530; -.
DR   KEGG; rno:304530; -.
DR   UCSC; RGD:1562861; rat.
DR   AGR; RGD:1562861; -.
DR   CTD; 51347; -.
DR   RGD; 1562861; Taok3.
DR   eggNOG; KOG0577; Eukaryota.
DR   InParanoid; Q53UA7; -.
DR   OrthoDB; 2879376at2759; -.
DR   PhylomeDB; Q53UA7; -.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013404; RAC2 GTPase cycle.
DR   PRO; PR:Q53UA7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0016740; F:transferase activity; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR051234; TAO_STE20_kinase.
DR   PANTHER; PTHR47167; SERINE/THREONINE-PROTEIN KINASE TAO1-LIKE PROTEIN; 1.
DR   PANTHER; PTHR47167:SF7; TAO KINASE 3; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Coiled coil; Cytoplasm; DNA damage; DNA repair;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..898
FT                   /note="Serine/threonine-protein kinase TAO3"
FT                   /id="PRO_0000086740"
FT   DOMAIN          24..277
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          316..372
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          405..424
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          565..596
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          452..502
FT                   /evidence="ECO:0000255"
FT   COILED          548..649
FT                   /evidence="ECO:0000255"
FT   COILED          753..871
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        337..370
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        565..594
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        147
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         30..38
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         53
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BYC6"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         357
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BYC6"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BYC6"
FT   MOD_RES         442
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         830
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BYC6"
SQ   SEQUENCE   898 AA;  105474 MW;  64B140980D0F01AC CRC64;
     MRKGVLKDPE IAELFFKEDP EELFIDLHEI GHGSFGAVYF ATNAHTNEVV AIKKMSYSGK
     QTHEKWQDIL KEVRFLQQLK HPNTIEYKGC YLKEHTAWLV MEYCLGSASD LLEVHKKPLQ
     EVEIAAITHG ALQGLAYLHF HSLIHRDIKA GNILLTEPGQ VKLADFGSAS MASPANSFVG
     TPYWMAPEVI LAMDEGQYDG KVDIWSLGIT CIELAERKPP LFNMNAMSAL YHIAQNDSPT
     LQSREWTDSF RRFVDYCLHK IPQERPAAAE LLRHDFIRRE RPPRVLIDLI QRTKDAVREL
     DNLQYRKMKK ILFQETRNGP LNESQEEEED SEQGSNLNRE VDSLGSIHSI PSVSVSTGSR
     SSSVNSMQEV MDEGSPELVM MQEDEGTVNS SSSMVHKKDH VFVRDEAGHG DPRPEPRPTQ
     SVQSRALHYR NRERFATIKS ASLVTRQIHE HEQENELREQ MSGYKRMRRQ HQKQLIALEN
     KLKAEMDEHR LKLQKEVETH ANNSSIELEK LAKKQVATIE KEAKVAAADE KKFQQQILAQ
     QKKDLTTFLE SQKKQYKICK EKIKEEMNED HSTPKKEKQE RISKHKENLQ HTQAEEEAHL
     LTQQRLYYDR NCRCFKRKIM TKRHEVEQQN IREELNKKRT QKEMEHAMLI RHDESTRELE
     YRQLHTLQKL RMDLIRLQHQ TELENQLEYN KRRERELHRK HVMELRQQPK NLKAMEMQIK
     KQFQDTCKVQ TKQYKALKNH QLEVTPKNEH KAILKTLKEE QTRKLAILAE QYEQSINEMM
     ASQALRLDEA QEAECQALRL QLQQEMELLN AYQSKIKMQT EAQHERELQK LEQRVSLRRA
     HLEQKIEEEL AALQKERSER IKTLLERQER ETETFDMESL RMGFGNLVTL DFPKEDYR
//
